RE:RE:My GUESS is Kaly might be bought out ????First yes kaly will get bought, that s the mission that rob has.
Fda approaval process obviously you don t understand the fda process, you should look at the fast track process that kaly is getting after stage 2, which will be completed this year.
And it s a big pharma that are way richer then th mj company that will buy kaly.
Why buy when the stock on phase 2 and not at the phase 3... if you followed properly you should be very excited.. phase 2 have incredible result for pre and treatment all of this with the low dosage...
Gvhd revenu estimation for the 6 most important country 600 Millions a year.....
Now if kaly get bought now it would be at a 1.00 minimu.... Mc 15 Millions + 10 Millions a year for testing... total expense under 50 Millions $$$$
Now if we sell after phase 2 is done and as good as it is..... we will probably be selling at over 300 millions.....
If we wait for phase 3 to be done this will get sold over 1 Billions $
NOW think like your the CEO of a big pharma when would you buy kaly ?
This is an incredible price to be with a FDA product of this level.
Long term is not far, do your DD., there a fortune to be made with this stock.
RE:My GUESS is Kaly might be bought out ????
bigbanktheory wrote: it's just a guess, and the reason being is that the big mj companies might not be hitting analysts expecatations, sure mj sales could start to pick up in the coming months, but in order to expand and grow revenues, they might start buying out good mj medical companies.
this is all just a guess, why would a major mj company wait for a phase three when phase two could be very successful, and possibly a much higher stock price, anyways, I'm holding for a year,
GL to all, do your own due diligence
If they want to expand and grow revenues... why would they buy Kaly? They wont see revs for 5 years minimum, and thats a best case scenario that they pass phase 2 and 3. PLus Kaly is the furthest thing from a good medical mj company. They are run like a lemonade stand.
I agree a medically focused LP like TRST would be smart to partner with Kaly. But like everyone else in the market (besides us), they are unwilling to take on the risk and cash burden of a phase 3 trial. We need someone to pay for Kaly's cash burn, and $10s of millions in clinical trials.
I doubled my position yesterday at 0.07. It is entirely possible I will lose my entire investment here. This is strictly a lotto play. I'm riskig $20,000 for the reward of $200,000. This is how NOT to invest, btw. But what can i say, im a gambler.
Read more at https://stockhouse.com/companies/bullboard?symbol=v.kaly&postid=29404384#70Cd2wMk8GBYjGsg.99